Literature DB >> 22234493

A modified juvenile arthritis damage index to improve articular damage assessment in juvenile idiopathic arthritis--enthesitis-related arthritis (JIA-ERA).

Yogesh Preet Singh1, Amita Aggarwal.   

Abstract

Juvenile arthritis damage index (JADI) consists of two parts which measure articular (JADI-A) and extra-articular (JADI-E) damage in patients with juvenile idiopathic arthritis (JIA). It does not include assessment of cardiac dysfunction and joint areas commonly affected in enthesitis-related arthritis (ERA) category of JIA. We have tried to study if modification of JADI will improve its performance in JIA-ERA. We studied 101 consecutive patients of JIA-ERA. JADI-A was modified (JADI-AM) to include damage assessment of tarsal joints and lumbar spine. JADI-E was modified (JADI-EM) to include assessment of symptomatic cardiac dysfunction. The performances of the modified and standard JADI were compared. Ninety-seven patients were male. The median age was 18 years (9-36). At a median disease duration of 6 years (1-24), joint damage was observed in 47 as assessed by JADI-A. JADI-AM could identify 11 more patients (N = 58) with articular damage. JADI-AM had good correlation with number of joints with limitation of movement (Spearman's [rS] = 0.9) and low to moderate correlation (rS < 0.7) with measures of disease activity and functional status. JADI-AM discriminated well among patients with different disability levels. Extra-articular damage was observed in 35, and modification of JADI-E with inclusion of cardiac dysfunction did not identify any additional patient. Thus, we propose a modification of the JADI-A (JADI-AM). In JIA-ERA, modification of JADI-A improves its ability to identify articular damage. Modification of the JADI-E may not be needed as symptomatic cardiac involvement is rare.

Entities:  

Mesh:

Year:  2012        PMID: 22234493     DOI: 10.1007/s10067-011-1928-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  34 in total

1.  A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies.

Authors:  R Burgos-Vargas; J Vázquez-Mellado; C Pacheco-Tena; A Hernández-Garduño; M V Goycochea-Robles
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

Review 2.  Quantitative joint assessment in rheumatoid arthritis.

Authors:  T Sokka; T Pincus
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

Review 3.  Medical treatment of juvenile idiopathic arthritis.

Authors:  Philip J Hashkes; Ronald M Laxer
Journal:  JAMA       Date:  2005-10-05       Impact factor: 56.272

4.  Juvenile ankylosing spondylitis.

Authors:  J R Ladd; J T Cassidy; W Martel
Journal:  Arthritis Rheum       Date:  1971 Sep-Oct

5.  Early disease course and predictors of disability in juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3 year prospective study.

Authors:  Anne M Selvaag; Gunhild Lien; Dag Sørskaar; Odd Vinje; Øystein Førre; Berit Flatø
Journal:  J Rheumatol       Date:  2005-06       Impact factor: 4.666

6.  Tarsitis as an initial manifestation of juvenile spondyloarthropathy.

Authors:  C Alvarez-Madrid; R Merino; J De Inocencio; J García-Consuegra
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

7.  HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis.

Authors:  Lillemor Berntson; Michael Damgård; Boel Andersson-Gäre; Troels Herlin; Susan Nielsen; Ellen Nordal; Marite Rygg; Marek Zak; Anders Fasth
Journal:  J Rheumatol       Date:  2008-09-01       Impact factor: 4.666

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  Anterior spinal flexion in healthy Mexican children.

Authors:  R Burgos-Vargas; J Lardizabal-Sanabria; G Katona
Journal:  J Rheumatol       Date:  1985-02       Impact factor: 4.666

10.  The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis.

Authors:  R Burgos-Vargas; J Vázquez-Mellado
Journal:  Arthritis Rheum       Date:  1995-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.